(Q52205646)

English

The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study.

scientific article published in October 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

C Häckel

1

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

K Radig

2

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

I Röse

3

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

A Roessner

4

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

publication date

1 October 1995

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Anatomy and Embryology

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

192

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

4

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

363-368

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of interleukin-1, tumor necrosis factor -beta, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclic AMP-dependent and -independent effects on tissue-type plasminogen activator activity in osteogenic sarcoma cells; evidence from phosphodiesterase inhibition and parathyroid hormone antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid isolation of high molecular weight urokinase from native human urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Types I and IV collagenolytic and plasminogen activator activities in preovulatory ovarian follicles

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of plasminogen activator in osteoblast-like cells by bone-resorbing hormones

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators, tissue degradation, and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant transforming growth factor type beta 3: biological activities and receptor-binding properties in isolated bone cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of plasminogen activator production by bone-resorbing hormones in normal and malignant osteoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/8554169

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00710105

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 April 2018

http://europepmc.org/abstract/MED/8554169

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52205646&oldid=2166061600"